Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02410 TYK MEDICINES-B
RT Nominal down6.665 -0.305 (-4.376%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others199,7783.977%192,137159,575157,51082,648
Land & other Lease Assets38,730-2.742%39,82250,26092,335107,548
Intangible Assets53,924-5.012%56,76962,41268,07173,730
Interests in Asso. & JCEs133,1322191.034%5,811000
Other Non-current Assets78,55477.897%44,15774,47121,51319,705

504,11848.841%338,696346,718339,429283,631
Current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Inventories0--0000
Trade Receivables0--0000
Cash & Bank Balances201,959-45.013%367,285460,463186,83090,762
Other Current Assets62,476-15.294%73,75676,17546,879183,968
Assets Held for Sale0--032,33700

264,435-40.043%441,041568,975233,709274,730
Current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Trade Payables15,175-66.400%45,16419,64232,1679,664
S-T Debt & Leases97,025-34.868%148,966170,36322,22623,492
Other Current Liabilities140,47723.613%113,64399,0641,246,586929,084
Liab asso w/ Assets Held for Sale0--01200

252,677-17.902%307,773289,0811,300,979962,240
Net Current Assets11,758-91.177%133,268279,894(1,067,270)(687,510)
Total Assets Less Current Liabilities515,8769.304%471,964626,612(727,841)(403,879)
Non-current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
L-T Debt & Leases52,6041267.403%3,8476,48519,50332,458
Other Non-current Liabilities202,50811.570%181,507147,565132,68964,412

255,11237.635%185,354154,050152,19296,870
Capital and Reserves
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
  Share Capital380,0660.000%380,066370,836307,356287,989
  Reserves(119,108)27.530%(93,396)98,252(1,191,836)(793,929)
  Others0--0000
Shareholders' Funds260,958-8.969%286,670469,088(884,480)(505,940)
Non-controlling Interests(194)223.333%(60)3,4744,4475,191
Others0--0000

260,764-9.018%286,610472,562(880,033)(500,749)
Commitments and Contingent Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Commitments------36,43315,54012,393
Contingent Liabilities------000
Remarks:  Real time quote last updated: 21/08/2026 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -24,897
%Change-77.806%
EPS / (LPS)RMB -0.070
NBV Per Share (¥)RMB 0.687
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.